UnitedHealth Group Inc (UNH) Shares Sold by Bristol Gate Capital Partners Inc.

Bristol Gate Capital Partners Inc. cut its position in UnitedHealth Group Inc (NYSE:UNH) by 6.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 155,397 shares of the healthcare conglomerate’s stock after selling 11,322 shares during the quarter. UnitedHealth Group makes up about 4.6% of Bristol Gate Capital Partners Inc.’s holdings, making the stock its 19th biggest position. Bristol Gate Capital Partners Inc.’s holdings in UnitedHealth Group were worth $30,435,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Blue Chip Partners Inc. bought a new stake in UnitedHealth Group in the 2nd quarter valued at $110,000. Bruderman Asset Management LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC bought a new stake in UnitedHealth Group in the 2nd quarter valued at $121,000. Finally, Acrospire Investment Management LLC boosted its holdings in UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.

In related news, insider Thomas E. Roos sold 975 shares of UnitedHealth Group stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $205.47, for a total transaction of $200,333.25. Following the completion of the transaction, the insider now directly owns 24,630 shares of the company’s stock, valued at approximately $5,060,726.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Larry C. Renfro sold 22,598 shares of UnitedHealth Group stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold a total of 34,630 shares of company stock valued at $7,669,416 over the last ninety days. 0.89% of the stock is owned by insiders.

UNH has been the subject of a number of research reports. Goldman Sachs Group initiated coverage on shares of UnitedHealth Group in a report on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target for the company. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 26th. Morgan Stanley increased their price target on shares of UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a report on Wednesday, October 18th. ValuEngine downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Finally, Leerink Swann reissued a “buy” rating and issued a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Three equities research analysts have rated the stock with a hold rating and twenty-five have assigned a buy rating to the company. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $229.54.

UnitedHealth Group Inc (NYSE:UNH) opened at $228.64 on Friday. The company has a market cap of $221,060.00, a PE ratio of 25.98, a PEG ratio of 1.53 and a beta of 0.66. UnitedHealth Group Inc has a 1-year low of $156.09 and a 1-year high of $231.77. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 0.52.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The company had revenue of $50.32 billion during the quarter, compared to the consensus estimate of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period last year, the firm earned $2.17 EPS. research analysts anticipate that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was first posted by Community Financial News and is the property of of Community Financial News. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://www.com-unik.info/2018/01/14/unitedhealth-group-inc-unh-shares-sold-by-bristol-gate-capital-partners-inc.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

What are top analysts saying about UnitedHealth Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for UnitedHealth Group and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit